A clinical case of a patient with newly diagnosed type 2 diabetes mellitus (DM2) is presented. The patient with a diagnosis of “impaired glucose tolerance” was not seen by an endocrinologist, did not follow a diet, independently discontinued the prescribed metformin, and did not control her glycemic level. She consulted an endocrinologist when started planning her pregnancy. The patient was diagnosed with type 2 diabetes mellitus, and combination glucose-lowering therapy was recommended. Next, the selection of therapy was assessed, the reliable long-term compensation of diabetes was achieved, and the long-awaited pregnancy occurred.
Conclusion. Therapy with gosogliptin has proven its effectiveness and safety in early treatment using rational combinations of drugs with a high safety profile

Keywords: gosogliptin, DPP-4 inhibitors, glycated hemoglobin, type 2 diabetes mellitus